• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症中的代谢综合征:炎症是致病原因之一吗?

The metabolic syndrome in schizophrenia: is inflammation a contributing cause?

机构信息

Department of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany.

出版信息

J Psychopharmacol. 2012 May;26(5 Suppl):33-41. doi: 10.1177/0269881111431622. Epub 2012 Apr 2.

DOI:10.1177/0269881111431622
PMID:22472311
Abstract

This non-systematic review of the literature summarizes the evidence that inflammation plays a major role in the psychopathology of schizophrenia and in the mechanisms that contribute to physical ill health that is commonly associated with schizophrenia. The impact of prenatal infections on the developing brain, the possible genetic link between the human lymphocyte antigen gene, inflammation, heart disease and diabetes, together with the increase in pro-inflammatory cytokines in the blood and cerebrospinal fluid provide convincing evidence that inflammation is a major factor in the pathology of this disorder. The changes in immune-related markers and specific neurotransmitters associated with the positive symptoms of schizophrenia are described. In addition, the possible mechanism whereby structural changes occur in the brain is associated with the neurotoxic effects of pro-inflammatory cytokines, together with the neurotoxic metabolites from the tryptophan-kynurenine pathway that is activated by pro-inflammatory cytokines, is also discussed. The role of effective antipsychotic drug treatment in attenuating the inflammatory response is described. However, evidence is limited regarding the causal connection between atypical antipsychotic drugs and the changes in glucose and lipid metabolism that could trigger the onset of physical ill health, including diabetes and heart disease. Indeed, there is evidence that there is a metabolic predisposition to diabetes in patients with schizophrenia that is exacerbated by obesity and thereby contributes to cardiovascular disease and other co-morbid illnesses. It is concluded that the effects of inflammatory mediators on the brain causally contribute to the pathology of schizophrenia and the ill health that accompanies the disorder.

摘要

这篇文献的非系统性综述总结了炎症在精神分裂症的精神病理学以及导致与精神分裂症相关的身体不健康的机制中起着重要作用的证据。产前感染对大脑发育的影响、人类淋巴细胞抗原基因、炎症、心脏病和糖尿病之间可能存在的遗传联系,以及血液和脑脊液中促炎细胞因子的增加,都提供了令人信服的证据,证明炎症是这种疾病发病机制的一个主要因素。本文描述了与精神分裂症阳性症状相关的免疫相关标志物和特定神经递质的变化。此外,还讨论了与促炎细胞因子的神经毒性作用以及由促炎细胞因子激活的色氨酸-犬尿氨酸途径的神经毒性代谢物相关的大脑结构变化的可能机制。还描述了有效抗精神病药物治疗在减轻炎症反应中的作用。然而,关于非典型抗精神病药物与葡萄糖和脂质代谢变化之间的因果关系的证据有限,这些变化可能引发身体不健康,包括糖尿病和心脏病。事实上,有证据表明,精神分裂症患者存在糖尿病的代谢易感性,肥胖会使其恶化,从而导致心血管疾病和其他合并症。总之,炎症介质对大脑的影响是导致精神分裂症发病机制和伴随该疾病的身体不健康的原因。

相似文献

1
The metabolic syndrome in schizophrenia: is inflammation a contributing cause?精神分裂症中的代谢综合征:炎症是致病原因之一吗?
J Psychopharmacol. 2012 May;26(5 Suppl):33-41. doi: 10.1177/0269881111431622. Epub 2012 Apr 2.
2
Effects of inflammation on the kynurenine pathway in schizophrenia - a systematic review.精神分裂症中炎症对犬尿氨酸通路的影响——系统综述。
J Neuroinflammation. 2020 Feb 15;17(1):56. doi: 10.1186/s12974-020-1721-z.
3
The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia.促炎细胞因子在精神分裂症的神经炎症和神经发生中的作用。
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:277-86. doi: 10.1016/j.pnpbp.2012.10.022. Epub 2012 Nov 1.
4
The role of inflammation in schizophrenia.炎症在精神分裂症中的作用。
Front Neurosci. 2015 Oct 21;9:372. doi: 10.3389/fnins.2015.00372. eCollection 2015.
5
Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.炎症在精神分裂症固有病理生理学和抗精神病药物引起的代谢紊乱中的作用。
Behav Brain Res. 2021 Mar 26;402:113101. doi: 10.1016/j.bbr.2020.113101. Epub 2021 Jan 14.
6
Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study.首发izophrenia 谱系障碍患者的心脏代谢风险:RAISE-ETP 研究的基线结果。
JAMA Psychiatry. 2014 Dec 1;71(12):1350-63. doi: 10.1001/jamapsychiatry.2014.1314.
7
Kynurenines: from the perspective of major psychiatric disorders.犬尿氨酸:从主要精神疾病的角度来看。
FEBS J. 2012 Apr;279(8):1375-85. doi: 10.1111/j.1742-4658.2012.08551.x. Epub 2012 Mar 27.
8
Metabolic syndrome associated with schizophrenia and atypical antipsychotics.代谢综合征与精神分裂症和非典型抗精神病药物相关。
Curr Diab Rep. 2010 Jun;10(3):209-16. doi: 10.1007/s11892-010-0112-8.
9
Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance.慢性奥氮平给药通过胰岛素抵抗啮齿动物模型中的炎症细胞因子引起代谢综合征。
Sci Rep. 2019 Feb 7;9(1):1582. doi: 10.1038/s41598-018-36930-y.
10
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].[制定重症精神疾病患者身体健康检查指南]
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.

引用本文的文献

1
Altered oral health and microbiota in drug-free patients with schizophrenia.精神分裂症未服药患者的口腔健康和微生物群改变
BMC Psychiatry. 2025 Mar 25;25(1):274. doi: 10.1186/s12888-025-06633-6.
2
Comprehension of gut microbiota and microRNAs may contribute to the development of innovative treatment tactics against metabolic disorders and psychiatric disorders.对肠道微生物群和微小RNA的理解可能有助于开发针对代谢紊乱和精神疾病的创新治疗策略。
Int J Physiol Pathophysiol Pharmacol. 2024 Dec 25;16(6):111-125. doi: 10.62347/WAZH2090. eCollection 2024.
3
Co-occurrence between mental disorders and physical diseases: a study of nationwide primary-care medical records.
精神障碍与躯体疾病的共病情况:一项基于全国基层医疗记录的研究。
Psychol Med. 2024 Nov 18;54(15):1-13. doi: 10.1017/S0033291724002575.
4
Elevated serum IL-17 A and CCL20 levels as potential biomarkers in major psychotic disorders: a case-control study.血清白细胞介素-17A 和 C 趋化因子配体 20 水平升高可作为主要精神病性障碍的潜在生物标志物:一项病例对照研究。
BMC Psychiatry. 2024 Oct 11;24(1):677. doi: 10.1186/s12888-024-06032-3.
5
Association between periodontal disease and schizophrenia: a bidirectional two-sample Mendelian randomization study.牙周病与精神分裂症的关联:一项双向两样本孟德尔随机化研究。
Sci Rep. 2024 Jul 29;14(1):17391. doi: 10.1038/s41598-024-65181-3.
6
Inflammatory Hematological Ratios in Adolescents with Mental Disorders: A Scoping Review.患有精神障碍青少年的炎症血液学指标:一项范围综述
Consort Psychiatr. 2024 Jul 6;5(2):45-61. doi: 10.17816/CP15514. eCollection 2024.
7
Understanding Health-Promoting Behaviors and Influential Factors in Schizophrenia Patients.理解精神分裂症患者的促进健康行为及影响因素。
Nutrients. 2024 May 15;16(10):1490. doi: 10.3390/nu16101490.
8
Peripheral and central biomarkers associated with inflammation in antipsychotic naïve first episode psychosis: Pilot studies.初发未使用抗精神病药物的首发精神病中与炎症相关的外周和中枢生物标志物:初步研究。
Schizophr Res. 2024 Feb;264:39-48. doi: 10.1016/j.schres.2023.11.012. Epub 2023 Dec 12.
9
Association of clinical symptoms and cardiometabolic dysregulations in patients with schizophrenia spectrum disorders.精神分裂症谱系障碍患者的临床症状与心脏代谢失调的关联。
Eur Psychiatry. 2023 Dec 13;67(1):e7. doi: 10.1192/j.eurpsy.2023.2477.
10
Putative role of immune reactions in the mechanism of tardive dyskinesia.免疫反应在迟发性运动障碍机制中的假定作用。
Brain Behav Immun Health. 2023 Sep 23;33:100687. doi: 10.1016/j.bbih.2023.100687. eCollection 2023 Nov.